InvestorsHub Logo
Followers 42
Posts 4868
Boards Moderated 0
Alias Born 04/30/2005

Re: XenaLives post# 215177

Friday, 10/18/2019 11:29:17 AM

Friday, October 18, 2019 11:29:17 AM

Post# of 459780
San Diego is only two hours away from me!

I'm definitely going down there to meet Dr. Missling and company.

Any questions that you would like me to ask him/them?

Let me know...

***************************************************************************************************************

12TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) DECEMBER 4-7, 2019 - SAN DIEGO, USA
https://ctad-alzheimer.com

Cut and paste from TTav66 - thank you.

CTAD update—In addition to the previously shared late breaking oral communication, Anavex and Ariana will also be presenting 2 gut microbiota focused posters:

P90: Gut Microbiota and Response to Blarcamesine (ANAVEX2- 73) in Alzheimer’s Disease Patients: Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis using KEM Artificial Intelligence

Mohammad AFSHAR (1), Coralie WILLIAMS (1), Frederic PARMENTIER (1), Adrien ETCHETO (1), Christopher MISSLING (2) - (1)Ariana Pharma, France, (2)Anavex, United States


P99: Levels of gut microbiota potentially regulated through anti-inflammatory effect identified as associated to response to Blarcamesine (ANAVEX2-73) in Alzheimer’s disease patients in 2-year Interim clinical data using KEM Artificial Intelligence analysis

Mohammad AFSHAR (1), Coralie WILLIAMS (1), Frederic PARMENTIER (1), Adrien ETCHETO (1), Christopher MISSLING (2) - (1)Ariana Pharma, France, (2)ANAVEX, United States


Previously shared presentation:
P11: Novel analytics framework for augmenting single-arm Phase 2a open label trials with RealWorld external control data: Application to the Blarcamesine (ANAVEX®2-73) study in Alzheimer’s disease matched with propensity corrected patients from Alzheimer’s Disease

Mohammad AFSHAR (1), Coralie WILLIAMS (1), Nanthara SRITHARAN (1), Frederic PARMENTIER (1), Federico GOODSAID (2), Christopher MISSLING (3) - (1)Ariana Pharma, France, (2)Regulatory Pathfinders, United States, (3)ANAVEX, United States

https://www.ctad-alzheimer.com/files/files/POSTER%20PRESENTATIONS.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News